Latest News and Press Releases

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique  Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...

PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.

ENGLEWOOD, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels and chemicals and carbon management, today announced the appointment of Joan Cetera as...

PRESS RELEASE — MARCH 31, 2026 Wendel Appoints Harper Mates  as CEO of Wendel North America  Wendel today announced a leadership transition for its North American Principal Investing business with...

COMMUNIQUÉ — 31.03.2026  Harper Mates est nommée CEO de Wendel North America Dans le cadre de son activité d’investissement pour compte propre, Wendel annonce la nomination de Harper Mates en tant...

Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO CapitalTetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals,...

New senior executives bring significant biopharma experience as Persica moves to next phase of its development London, UK, 23 March 2026 - Persica Pharmaceuticals Limited (Persica), a clinical stage...

Syncona’s maturing portfolio entering a period of significant clinical and strategic milestones, positioning the business for near-term value creation and enabling returns to shareholdersHigh-calibre...

Strengthening the clinical leadership as the Company progresses to the clinic with its BRD9 Targeted Glue™, AMX-883, in acute myeloid leukemiaAmphista continues to advance its SMARCA and TEAD...

Commit Biologics appoints seasoned biotech entrepreneur Thomas L. F. Montgomery Andresen, PhD, as Chief Executive Officer.